CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
1.150
0.00 (0.00%)
At close: Jul 16, 2026, 4:00 PM EDT
1.150
0.00 (0.00%)
After-hours: Jul 16, 2026, 4:10 PM EDT
CEL-SCI Market Cap
CEL-SCI has a market cap or net worth of $20.1 million as of July 16, 2026. Its market cap has decreased by -16.53% in one year.
Market Cap
20.10M
Enterprise Value
30.73M
1-Year Change
-16.53%
Ranking
Category
Stock Price
$1.15
ChartMarket Cap Chart
Since February 10, 1992, CEL-SCI's market cap has decreased from $126.81M to $20.10M, a decrease of -84.15%. That is a compound annual growth rate of -5.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 20.10M | -54.56% |
| Dec 31, 2025 | 44.23M | 49.58% |
| Dec 31, 2024 | 29.57M | -78.25% |
| Dec 29, 2023 | 135.95M | 32.44% |
| Dec 30, 2022 | 102.65M | -66.57% |
| Dec 31, 2021 | 307.04M | -33.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celularity | 22.20M |
| Skye Bioscience | 21.48M |
| Tevogen Bio Holdings | 21.42M |
| Cellectar Biosciences | 21.26M |
| NewcelX | 20.73M |
| Atossa Therapeutics | 19.89M |
| Longeveron | 19.88M |
| Jasper Therapeutics | 19.74M |